Skip to main content
. 2022 Nov 26;11(23):6981. doi: 10.3390/jcm11236981

Figure 2.

Figure 2

Cumulative survival. (A) Cumulative survival of the entire study group. The cumulative survival rates at 1, 3, 5, and 7 years were 94.4% (95% CI:84.1–98.2%), 90.6% (79.3–96.0%), 86.0% (73.3–93.2%), and 70.4% (53.7–83.0%), respectively. (B) Cumulative survival of each group. The 7-year survival rates in the bTEVAR group and the hTEVAR group were 71.5% (47.6–87.4%) and 71.0% (47.3–87.0%), respectively. There were no significant differences between the two groups (Log-rank p = 0.958).